<M Stanley Report>: CRM Business Revamp Aids MICROPORT in Reaching Financial Objectives
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 30 2025
0mins
Source: aastocks
Restructuring and Acquisition: MICROPORT is restructuring its CRM business, with its subsidiary CARDIOFLOW-B issuing new shares to acquire Cardiac Rhythm Management (CRM) for USD680 million, resulting in a decrease of MICROPORT's stake in CARDIOFLOW-B from 46.12% to 44.45%.
Financial Improvements: The refinancing of CRM will reduce interest expenses significantly, aiding MICROPORT in its goal to lower its debt ratio from 70% to around 50% in 1-3 years and further to 30-35% in 3-5 years, while Morgan Stanley views this as a crucial cleanup event for the company.
Analyst Views on 00853
Wall Street analysts forecast 00853 stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for 00853 is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 12.180
Low
Averages
High
Current: 12.180
Low
Averages
High
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
